Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review

Genome‐wide approaches applied for the identification of new hereditary colorectal cancer (CRC) genes, identified several potential causal genes, including RPS20, IL12RB1, LIMK2, POLE2, MRE11, POT1, FAN1, WIF1, HNRNPA0, SEMA4A, FOCAD, PTPN12, LRP6, POLQ, BLM, MCM9, and the epigenetic inactivation of PTPRJ. Here we attempted to validate the association between variants in these genes and nonpolyposis CRC by performing a mutational screening of the genes and PTPRJ promoter methylation analysis in 473 familial/early‐onset CRC cases, a systematic review of the published cases, and assessment of allele frequencies in control population. In the studied cohort, 24 (5%) carriers of (predicted) deleterious variants in the studied genes and no constitutional PTPRJ epimutations were identified. Assessment of allele frequencies in controls compared with familial/early‐onset patients with CRC showed association with increased nonpolyposis CRC risk of disruptive variants in RPS20, IL12RB1, POLE2, MRE11 and POT1, and of FAN1 c.149T>G (p.Met50Arg). Lack of association was demonstrated for LIMK2, PTPN12, LRP6, PTPRJ, POLQ, BLM, MCM9 and FOCAD variants. Additional studies are required to provide conclusive evidence for SEMA4A, WIF1, HNRNPA0 c.−110G>C, and FOCAD large deletions.

[1]  L. Cannon-Albright,et al.  A novel ribosomal protein S20 variant in a family with unexplained colorectal cancer and polyposis , 2019, bioRxiv.

[2]  G. Capellá,et al.  Contribution to colonic polyposis of recently proposed predisposing genes and assessment of the prevalence of NTHL1‐ and MSH3‐associated polyposes , 2019, Human mutation.

[3]  J. Malvehy,et al.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families , 2019, The British journal of dermatology.

[4]  S. Puig,et al.  Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma , 2019, JAMA dermatology.

[5]  T. Pons,et al.  Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer. , 2019, Cancer letters.

[6]  Sean V Tavtigian,et al.  Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine , 2019, The Journal of pathology.

[7]  D. Stoppa-Lyonnet,et al.  Prevalence of Pathogenic Variants of FAN1 in More Than 5000 Patients Assessed for Genetic Predisposition to Colorectal, Breast, Ovarian, or Other Cancers. , 2019, Gastroenterology.

[8]  Joel N Hirschhorn,et al.  Burden Testing of Rare Variants Identified through Exome Sequencing via Publicly Available Control Data. , 2018, American journal of human genetics.

[9]  S. Chanock,et al.  Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma , 2018, British journal of haematology.

[10]  A. von Haeseler,et al.  Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria , 2018, G3: Genes, Genomes, Genetics.

[11]  Nathanael D. Moore,et al.  Inherited DNA Repair Defects in Colorectal Cancer , 2018, bioRxiv.

[12]  R. Scott,et al.  Use of multigene‐panel identifies pathogenic variants in several CRC‐predisposing genes in patients previously tested for Lynch Syndrome , 2017, Clinical genetics.

[13]  M. Urioste,et al.  The wide spectrum of POT1 gene variants correlates with multiple cancer types , 2017, European Journal of Human Genetics.

[14]  Aung Ko Win,et al.  Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes , 2017, Molecular genetics & genomic medicine.

[15]  S. Gruber,et al.  Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort , 2017, Oncotarget.

[16]  S. Plon,et al.  Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines , 2017, bioRxiv.

[17]  Laura Valle,et al.  Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  A. Lerário,et al.  A new POT1 germline mutation—expanding the spectrum of POT1-associated cancers , 2017, Familial Cancer.

[19]  P. Broderick,et al.  CanVar: A resource for sharing germline variation in cancer patients , 2016, F1000Research.

[20]  Trevor Hastie,et al.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. , 2016, American journal of human genetics.

[21]  P. Broderick,et al.  Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer , 2016, Nature Communications.

[22]  J. Hampe,et al.  Correspondence: SEMA4A variation and risk of colorectal cancer , 2016, Nature Communications.

[23]  C. Boland,et al.  Correspondence: Reply to ‘SEMA4A variation and risk of colorectal cancer' , 2016, Nature Communications.

[24]  P. J. Sjöström,et al.  Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability , 2016, Science.

[25]  L. Vreede,et al.  Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility , 2016, PLoS genetics.

[26]  Lincoln D. Stein,et al.  Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer. , 2016, Cancer letters.

[27]  V. Meiner,et al.  Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure. , 2015, Cancer genetics.

[28]  F. Setién,et al.  A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families , 2015, Nature Communications.

[29]  A. Hoischen,et al.  Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer , 2015, Scientific Reports.

[30]  A. Valencia,et al.  Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair. , 2015, Gastroenterology.

[31]  Peter Nürnberg,et al.  Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas , 2015, International journal of cancer.

[32]  Vicente Martín,et al.  Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. , 2015, Gaceta sanitaria.

[33]  L. Kiemeney,et al.  Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development , 2015, The Journal of pathology.

[34]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[35]  M. Ligtenberg,et al.  Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation , 2015, Familial Cancer.

[36]  C. Boland,et al.  Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers , 2015, Familial Cancer.

[37]  M. Speicher,et al.  Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X , 2014, Nature Communications.

[38]  S. Scherer,et al.  Germline Mutation of RPS20, Encoding a Ribosomal Protein, Causes Predisposition to Hereditary Nonpolyposis Colorectal Carcinoma Without DNA Mismatch Repair Deficiency , 2014, Gastroenterology.

[39]  Thomas M. Keane,et al.  POT1 loss-of-function variants predispose to familial melanoma , 2014, Nature Genetics.

[40]  X. Hua,et al.  Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma , 2014, Nature Genetics.

[41]  Alexander Hoischen,et al.  KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. , 2012, Brain : a journal of neurology.

[42]  A. V. van Kessel,et al.  Identification of candidate predisposing copy number variants in familial and early‐onset colorectal cancer patients , 2011, International journal of cancer.

[43]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[44]  I. Tomlinson,et al.  Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer. , 2010, Gastroenterology.

[45]  M. Esteller,et al.  Novel methylation panel for the early detection of colorectal tumors in stool DNA. , 2010, Clinical colorectal cancer.

[46]  Olive Lloyd-Baker.  IDENTIFICATION OF NOVEL , 1964 .

[47]  T. Pons,et al.  Germline variation in O-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer , 2019 .

[48]  P. Broderick,et al.  Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review. , 2017, Gastroenterology.

[49]  M. Dyer,et al.  Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. , 2016, Blood.

[50]  R. Gibbs,et al.  Germline mutations in shelterin complex genes are associated with familial glioma. , 2015, Journal of the National Cancer Institute.

[51]  J. A. Acree.  On mutation , 1980 .